| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | NEOGENOMICS INC | 2,038,988 | 16,393,000 | 7.59% | ||
| 2 | AKORN INC | 525,737 | 14,976,000 | 6.94% | ||
| 3 | ATRICURE INC | 922,590 | 13,036,000 | 6.04% | ||
| 4 | LHC GROUP INC COM | 226,943 | 9,822,000 | 4.55% | ||
| 5 | ENZO BIOCHEM INC | 1,364,963 | 8,149,000 | 3.78% | ||
| 6 | HARVARD BIOSCIENCE INC | 2,740,203 | 7,837,000 | 3.63% | ||
| 7 | ENTELLUS MEDICAL INC | 396,291 | 7,240,000 | 3.35% | ||
| 8 | TELIGENT INC NEW | 1,007,530 | 7,194,000 | 3.33% | ||
| 9 | Oxford Immunotec Global PLC | 700,849 | 6,308,000 | 2.92% | ||
| 10 | AMEDISYS INC COM | 120,778 | 6,097,000 | 2.82% | ||
| 11 | NXSTAGE MED INC COM | 254,113 | 5,509,000 | 2.55% | ||
| 12 | LEMAITRE VASCULAR INC COM | 385,562 | 5,502,000 | 2.55% | ||
| 13 | ORTHOFIX INTERNATIONAL NV | 129,745 | 5,501,000 | 2.55% | ||
| 14 | HEALTHSTREAM INC COM | 205,298 | 5,445,000 | 2.52% | ||
| 15 | BIOSCRIP INC | 2,092,082 | 5,335,000 | 2.47% | ||
| 16 | Model N Inc | 397,152 | 5,302,000 | 2.46% | ||
| 17 | LIGAND PHARMACEUTICALS INC | 42,120 | 5,024,000 | 2.33% | ||
| 18 | ENVISION HEALTHCARE HLDGS INC | 191,946 | 4,870,000 | 2.26% | ||
| 19 | K2M GROUP HLDGS INC COM | 281,975 | 4,376,000 | 2.03% | ||
| 20 | ARATANA THERAPEUTICS INC COM | 684,921 | 4,329,000 | 2.01% | ||
| 21 | MEDICINES CO | 125,889 | 4,234,000 | 1.96% | ||
| 22 | BIOTELEMETRY INC COM | 255,163 | 4,159,000 | 1.93% | ||
| 23 | LDR HLDG CORP COM | 105,780 | 3,909,000 | 1.81% | ||
| 24 | SPECTRANETICS CORP | 198,219 | 3,709,000 | 1.72% | ||
| 25 | RTI SURGICAL HOLDINGS INC COM | 987,225 | 3,544,000 | 1.64% | ||
| 26 | PHYSICIANS RLTY TR | 155,849 | 3,274,000 | 1.52% | ||
| 27 | ENDOLOGIX INC | 258,431 | 3,220,000 | 1.49% | ||
| 28 | CYNAPSUS THERAPEUTICS INC | 188,577 | 3,159,000 | 1.46% | ||
| 29 | BLUEBIRD BIO INCORPORATED | 67,044 | 2,902,000 | 1.34% | ||
| 30 | VERACYTE INC | 546,021 | 2,746,000 | 1.27% | ||
| 31 | BIO TECHNE CORP | 24,146 | 2,723,000 | 1.26% | ||
| 32 | ALKERMES PLC SHS | 62,068 | 2,683,000 | 1.24% | ||
| 33 | TEARLAB CORP | 3,760,430 | 2,407,000 | 1.12% | ||
| 34 | IMMUNOMEDICS INC | 987,854 | 2,292,000 | 1.06% | ||
| 35 | STREAMLINE HEALTH SOLUTIONS COM | 1,792,041 | 2,150,000 | 1.00% | ||
| 36 | VERTEX PHARMACEUT | 23,835 | 2,050,000 | 0.95% | ||
| 37 | ARRAY BIOPHARMA INC COM | 554,841 | 1,975,000 | 0.91% | ||
| 38 | CEPHEID | 62,178 | 1,912,000 | 0.89% | ||
| 39 | QUIDEL CORP COM | 83,698 | 1,495,000 | 0.69% | ||
| 40 | NANOSTRING TECHNOLOGIES INC | 118,547 | 1,494,000 | 0.69% | ||
| 41 | BIOMARIN | 18,515 | 1,440,000 | 0.67% | ||
| 42 | HUMANA | 3,540 | 637,000 | 0.30% | ||
| 43 | AETNA INC NEW | 5,215 | 637,000 | 0.30% | ||
| 44 | BRISTOL MYERS SQUIBB CO | 8,290 | 610,000 | 0.28% | ||
| 45 | BECTON DICKINSON & CO | 3,395 | 576,000 | 0.27% | ||
| 46 | ANTHEM INC | 4,095 | 538,000 | 0.25% | ||
| 47 | NOVARTIS A G | 6,070 | 501,000 | 0.23% | ||
| 48 | ALLERGAN PLC | 2,035 | 470,000 | 0.22% | ||
| 49 | JOHNSON & JOHNSON | 3,820 | 463,000 | 0.21% | ||
| 50 | Agile Therapeutics, Inc. | 59,701 | 454,000 | 0.21% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001387131-16-006614, filed 2016.08.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
